Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis

Status Completed

Clinical Trial Summary

The purpose of this phase 3 confirmatory study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of treatment of uveitis.

Clinical Trial Description

The objective of this phase 3 study is to assess the efficacy and safety of 0.05% difluprednate ophthalmic emulsion (DFBA) in patients with endogenous anterior uveitis, in comparison with 0.1% betamethasone sodium phosphate ophthalmic solution (BP). ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00406887
Study type	Interventional
Source	Sirion Therapeutics, Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	August 2002
Completion date	November 2003

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT01280669` - Intravitreal Sirolimus as Therapeutic Approach to Uveitis	Phase 2
Terminated	`NCT03656692` - Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)	Phase 4
Completed	`NCT02255032` - Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis	Phase 2
Recruiting	`NCT05101928` - Ozurdex Monotherapy Trial	Phase 4
Completed	`NCT00167583` - Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB)	Phase 3
Completed	`NCT02595398` - Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis	Phase 3
Recruiting	`NCT00407316` - Quality of Life and Visual Function in Uveitis Patients	Phase 0
Completed	`NCT02746991` - Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis	Phase 3
Recruiting	`NCT06085079` - Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study	Phase 4
Completed	`NCT02725177` - Ocular Sarcoidosis Open Label Trial of ACTHAR Gel	N/A
Completed	`NCT00908466` - Sirolimus as Therapeutic Approach to Uveitis	Phase 1
Completed	`NCT00615693` - Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis	Phase 2
Completed	`NCT00404612` - A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis	Phase 3
Completed	`NCT00404885` - A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis	Phase 3
Completed	`NCT00404742` - A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis	Phase 3
Completed	`NCT01789320` - Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis	Phase 1/Phase 2
Completed	`NCT02952001` - MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Completed	`NCT00407056` - Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis	Phase 3
Completed	`NCT03097315` - Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis	Phase 3